✦ LIBER ✦

Radiosensitivity testing of human primary brain tumor specimens

✍ Scribed by M.Joan Allalunis-Turner; Geraldine M. Barron; Rufus S. Day III; Dorcas S. Fulton; Raul C. Urtasun

Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 689 KB
Volume: 23
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(92)90751-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiosensitization of primary human tumo

Radiosensitization of primary human tumor cell cultures by N-methylformamide

✍ Carla Arundel; Susan Bock; William A. Brock; Philip J. Tofilon 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 613 KB

Cellular radiosensitivity of a rat brain

Cellular radiosensitivity of a rat brain tumor

✍ John T. Leith; Wolfgang A. Schilling; Kenneth T. Wheeler 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 515 KB

Radiosensitivity testing of human malign

Radiosensitivity testing of human malignant gliomas

✍ J. Ramsay; R. Ward; N.M. Bleehen 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 709 KB

Comparison of in vitro radiosensitivity

Comparison of in vitro radiosensitivity of primary human tumor cell cultures for different histological types

✍ L.J. Peters; F. Baker; W.A. Brock 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 240 KB

Radiosensitization of human tumor cells

Radiosensitization of human tumor cells by alpha-difluoromethylornithine

✍ A. Courdi; G. Milano; M. Bouclier; C. M. Lalanne 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 French ⚖ 440 KB

ALPHA-DIFLUOROMETHY LORNITHINE ## CIRD (Centre International de Recherches The effect of polyamine depletion on the radiosensitivity of a human tumor cell line was investigated. CAL 18 A cells, derived from a breast carcinoma, were incubated with alpha-difluoromethylornithine (DFMO) a specific a

Radiotherapy of primary malignant brain

Radiotherapy of primary malignant brain tumors

✍ David A. Larson; William M. Wara 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 2 views

Radiotherapy is usually recommended for patients with a primary malignant brain tumor. The foundation for its use is grounded on the results of randomized trials for malignant gliomas which have demonstrated a relationship between survival and external beam radiation dose. Although similar trials ha